Status | Study |
Active, not recruiting |
Study Name: N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma Condition: Neuroblastoma Date: 2009-04-18 Interventions: Drug: Bevacizumab Every course |
Terminated |
Study Name: Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma Condition: Neuroblastoma Date: 2008-12-11 Interventions: Drug: Temsirolimus Temsirolimu |
Completed |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma Condition: Neuroblastoma Date: 2007-03-20 Interventions: Biological: bevacizumab Biological: filgra |
Completed |
Study Name: Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma Condition: Neuroblastoma Date: 2006-04-05 Interventions: Drug: irinotecan hydrochloride |
Completed |
Study Name: 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma Condition: Neuroblastoma Date: 2006-02-16 Interventions: Biological: filgrastim Radiation: iobengua |
Completed |
Study Name: Therapy for Children With Advanced Stage High Risk Neuroblastoma Condition: Neuroblastoma Date: 2005-09-12 Interventions: Drug: Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfa |
Active, not recruiting |
Study Name: Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients Condition: Neuroblastoma Date: 2004-06-17 Interventions: Biological: 14g2a.zeta chimeric receptor transduced autologous EBV specific cytotoxic T-lymphocytes (EBV-CTL) w/o lymphodepletion |
Completed |
Study Name: hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma Condition: Neuroblastoma Date: 2004-05-14 Interventions: Biological: hu14.18-Interleukin-2 fusion protein Given IV |
Completed |
Study Name: Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma Condition: Neuroblastoma Date: 2002-05-13 Interventions: Biological: beta-glucan Biological: monocl |
Completed |
Study Name: Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma Condition: Neuroblastoma Date: 2001-10-11 Interventions: Drug: carboplatin Drug: cyclophosphamide |